On-Demand Webinar

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Watch our on-demand webinar on empiric PK time-course scaling and learn how Certara’s translational experts…

Certara2025 年 11 月 13 日

Announcement

Certara 一项研究显示，半数美国人不知道 FDA 和 NIH 正计划逐步淘汰新药的动物实验

Certara’s new survey findings show that 50% of Americans are unaware of FDA and NIH…

Certara2025 年 11 月 12 日

On-Demand Webinar

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

In today’s market where long development timelines and investor caution can slow progress, MIDD offers…

Certara2025 年 11 月 10 日

Guide

降低药物设计风险：早期可行性评估如何改变生物治疗药物的研发

Learn how Early Feasibility Assessment and QSP modeling improve drug design, de-risk feasibility studies, &…

Certara2025 年 11 月 7 日

On-Demand Webinar

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Watch the on-demand webinar on avoiding drug launch failure. Learn how smarter development, evidence, and…

Certara2025 年 11 月 6 日

On-Demand Webinar

按时交付：借助定量药理学分析洞见，顺利推进监管申报

Watch this on-demand webinar to learn how pharmacometrics supports NDA, BLA, and global regulatory submissions.…

Certara2025 年 11 月 3 日

Publication

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…

Certara2025 年 10 月 31 日

Blog

Key lessons & opportunities in applying NCA and PopPK to ADCs

Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide…

Certara2025 年 10 月 24 日

Blog

Bottlenecks to breakthroughs: Tackling challenges in QSP modeling

QSP modeling holds huge promise, but complexity and scalability limit adoption. We review the challenges…

Certara2025 年 10 月 22 日

On-Demand Webinar

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

Learn how model-informed drug development, clinical pharmacology, and regulatory strategy support successful pediatric drug development…

Certara2025 年 10 月 21 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

建模与模拟

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Certara 一项研究显示，半数美国人不知道 FDA 和 NIH 正计划逐步淘汰新药的动物实验

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

降低药物设计风险：早期可行性评估如何改变生物治疗药物的研发

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

按时交付：借助定量药理学分析洞见，顺利推进监管申报

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Key lessons & opportunities in applying NCA and PopPK to ADCs

Bottlenecks to breakthroughs: Tackling challenges in QSP modeling

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

订阅时事通讯

快捷链接

解决方案

联系我们